07/13/2021
I invite an Interview by the Media about this article: https://news.yahoo.com/biden-picks-ex-west-virginia-161420975.html - As could have been predicted, President Biden has chosen someone with a demand side bias, or physician, to lead the Office of National Drug Control Policy (ONDCP). Dr. Gupta's credentials are laudable, but under the Biden administration strategy & outlook, his focus will likely be on the demand side of the illegal drug market equation, and thus not likely to make a dent in the importation into the U.S. of dangerous and illicitly manufactured drugs like Methamphetamine and Fentanyl that are produced en masse in Mexico. The Director of ONDCP must equally focus on the supply side of the problem, such as working with Mexico and other supply side nations like China, to stop the supply of essential and precursor chemicals used to manufacture the illegal and dangerous drugs that are making their way into the U.S. The demand side notion that drug abuse is a sickness, and not a choice, only enables drug users by providing them a crutch on which they can stand, to continue justifying their drug use. It's unfortunate that our government cannot provide even-handed drug control policies that focus equally on demand and supply, and not only one or the other. This is why we fail to reduce drug abuse in the U.S. ... the lack of continuity in policy development.
President Joe Biden is nominating West Virginia's former health commissioner as the nation's top anti-drug official, tapping a doctor who served on the front lines of the nation's opioid epidemic. The White House said Tuesday that Dr. Rahul Gupta will be the first physician to lead the Office of Nat...
